Serum caveolin-1 levels in patients with preeclampsia

References

• Murphy DJ, Stirrat GM. Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy. 2000;19:221–231.
   PubMed Web of Science ®Google Scholar
• Walker JJ. Pre-eclampsia. Lancet. 2000;356:1260–1265.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Maternal and uteroplacental hemodynamics for the classification and prediction of preeclampsia. Hypertension. 2008;52:805–806.
   PubMed Web of Science ®Google Scholar
• Valensise H, Vasapollo B, Gagliardi G, et al. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52:873–880.
   PubMed Web of Science ®Google Scholar
• Dekker GA, van Geijn HP. Endothelial dysfunction in preeclampsia. part I: primary prevention. Therapeutic perspectives. J Perinat Med. 1996;24:99–117.
   PubMed Web of Science ®Google Scholar
• Von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22:143–148.
   PubMed Web of Science ®Google Scholar
• Onah HE, Iloabachie GC. Conservative management of early-onset pre-eclampsia and fetomaternal outcome in Nigerians. J Obstet Gynaecol. 2002;22:357–362.
   PubMedGoogle Scholar
• Crispi F, Llurba E, Domínguez C, et al. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol. 2008;31:303–309.
   PubMed Web of Science ®Google Scholar
• García-Cardeña G, Fan R, Stern DF, et al. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem. 1996;271:27237–27240.
   PubMed Web of Science ®Google Scholar
• Quest AF, Leyton L, Párraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol. 2004;82:129–144.
   PubMed Web of Science ®Google Scholar
• Marsboom G, Chen Z, Yuan Y, et al. Aberrant caveolin-1-mediated Smad signaling and proliferation identified by analysis of adenine 474 deletion mutation (c.474delA) in patient fibroblasts: a new perspective on the mechanism of pulmonary hypertension. Mol Biol Cell. 2017;28:1177–1185.
   PubMed Web of Science ®Google Scholar
• Felley-Bosco E, Bender FC, Courjault-Gautier F, et al. Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. Proc Natl Acad Sci USA. 2000;97:14334–14339.
   PubMed Web of Science ®Google Scholar
• Huang J, Wolk JH, Gewitz MH, et al. Caveolin-1 expression during the progression of pulmonary hypertension. Exp Biol Med (Maywood). 2012;237:956–965.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Zhao YD, Mirza MK, et al. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest. 2009;119:20092009–20092018.
   Web of Science ®Google Scholar
• Williams JJ, Palmer TM. Cavin-1: caveolae-dependent signalling and cardiovascular disease. Biochm Soc Trans. 2014;42:284–288.
   PubMed Web of Science ®Google Scholar
• Feng L, Liao WX, Luo Q, et al. Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae. J Cell Physiol. 2012;227:2480–2491.
   PubMed Web of Science ®Google Scholar
• Tahir SA, Park S, Thompson TC. Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells. Cancer Biol Ther. 2009;8:2284–2296.
   PubMed Web of Science ®Google Scholar
• Lei Y, Song M, Wu J, et al. eNOS Activity in CAV1 knockout mouse Eyes. Invest Ophthalmol Vis Sci. 2016;57:2805–2813.
   PubMed Web of Science ®Google Scholar
• Smith-Jackson K, Hentschke MR, Poli-de-Figueiredo CE, et al. Placental expression of eNOS, iNOS and the major protein components of caveolae in women with pre-eclampsia. Placenta 2015;36:607–610.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122: 1122–1131.
   PubMed Web of Science ®Google Scholar
• Viechtbauer W, Smits L, Kotz D, et al. A simple formula for the calculation of sample size in pilot studies. J Clin Epidemiol. 2015;68:1375–1379. Nov.
   PubMed Web of Science ®Google Scholar
• Du L, He F, Kuang L, et al. eNOS/iNOS and endoplasmic reticulum stress-induced apoptosis in the placentas of patients with preeclampsia. J Hum Hypertens. 2017;31:49–55.
   PubMed Web of Science ®Google Scholar
• Briand N, Dugail I, Le Lay S. Cavin proteins: new players in the caveolae field. Biochimie 2011;93:71–77.
   PubMed Web of Science ®Google Scholar
• Drab M, Verkade P, Elger M, et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 2001;293:2449–2452.
   PubMed Web of Science ®Google Scholar
• Rath G, Dessy C, Feron O. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation. J Physiol Pharmacol. 2009;60:105–109.
   PubMed Web of Science ®Google Scholar
• Hentschke M, Smith-Jackson K, Poli-de-Figueiredo CE, et al. PP011. Placental expression of the major protein components of caveolae, eNOS and iNOS in pre-eclampsia. Pregnancy Hypertens. 2013;3:71.
   PubMedGoogle Scholar
• Chen F, Barman S, Yu Y, et al. Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species. Free Radic Biol Med. 2014;73:201–213.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang AX, Liu Z, et al. The trafficking/interaction of eNOS and caveolin-1 induced by insulin modulates endothelial nitric oxide production. Mol Endocrinol. 2009;23:1613–1623.
   PubMedGoogle Scholar
• Shiroto T, Romero N, Sugiyama T, et al. Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium. Plos One. 2014;9:e87871.
   PubMed Web of Science ®Google Scholar
• Wang K, Zheng J. Signaling regulation of fetoplacental angiogenesis. J Endocrinol. 2012;212:243–255.
   PubMed Web of Science ®Google Scholar
• Chen DB, Zheng J. Regulation of placental angiogenesis. Microcirculation. 2014; 21:15–25.
   PubMed Web of Science ®Google Scholar
• Cudmore MJ, Ahmad S, Sissaoui S, et al. Loss of Akt activity increases circulating soluble endoglin release in preeclampsia: identification of inter-dependency between Akt-1 and heme oxygenase-1. Eur Heart J. 2012;33:1150–1158.
   PubMed Web of Science ®Google Scholar